Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: A preliminary report

Bipolar Disorders

Volumn 13, Issue 3, 2011, Pages 294-302

  Sajatovic, Martha ^a   Gildengers, Ariel ^b   Al Jurdi, Rayan K ^c   Gyulai, Laszlo ^d   Cassidy, Kristin A ^a   Greenberg, Rebecca L ^e   Bruce, Martha L ^e   Mulsant, Benoit H ^b,f   Ten Have, Thomas ^d   Young, Robert C ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anticonvulsant; Bipolar disorder; Depression; Elderly; Geriatric; Lamotrigine; Mood stabilizer

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; CLINICAL GLOBAL IMPRESSION SCALE; DREAMING; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FALLING; FATIGUE; FEMALE; FUNCTIONAL STATUS; GERIATRIC CARE; HAMILTON SCALE; HUMAN; HYPONATREMIA; LABORATORY TEST; LASSITUDE; MAJOR CLINICAL STUDY; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; PATIENT SATISFACTION; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; REMISSION; SEXUAL AROUSAL; SIDE EFFECT; SKIN NECROSIS; SLEEP DISORDER; SOMNOLENCE; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSTEADINESS; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; ANTIMANIC AGENTS; BIPOLAR DISORDER; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TRIAZINES;

EID: 79959225680     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2011.00923.x     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention (CDC). Trends in aging-United States and worldwide. MMWR Morb Mortal Wkly Rep 2003; 52: 101-104.
2. Jeste DV, Alexopoulos GS, Bartels SJ et al. Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry 1999; 56: 848-853.
3. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord 2004; 6: 343-367.
4. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 2006; 67: 215-221.
5. Gildengers AG, Mulsant BH, Begley AE et al. A pilot study of standardized treatment in geriatric bipolar disorder. Am J Geriatr Psychiatry 2005; 13: 319-323.
6. Young RC, Gyulai L, Mulsant BH et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry 2004; 12: 342-357.
7. Geddes J, Goodwin G, Rendell J, Hainsworth J, Van der Gucht E, Young H. New trial should clarify lithium use in bipolar disorder. BMJ 2002; 325: 441.
8. Young RC, Schulberg HC, Gildengers AG et al. Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. Bipolar Disord 2010; 12: 56-67.
9. Altshuler LL, Gitlin MJ, Mintz J, Leight KL, Frye MA. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002; 63: 807-811.
10. Grunze H. Reevaluating therapies for bipolar depression. J Clin Psychiatry 2005; 66 (Suppl. 5): 17-25.
11. Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537.
12. Nierenberg AA, Ostacher MJ, Calabrese JR et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 2006; 163: 210-216.
13. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159 (Suppl. 4): 1-50.
14. Fountoulakis KN, Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 2008; 11: 999-1029.
15. Fuller M, Sajatovic M. Drug Information Handbook for Psychiatry, 7th ed. Cleveland: LexiComp Inc., 2009.
16. Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11: 225-255.
17. Calabrese JR, Huffman RF, White RL et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008; 10: 323-333.
18. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009; 194: 4-9.
19. van der Loos ML, Mulder PG, Hartong EG et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebocontrolled trial. J Clin Psychiatry 2009; 70: 223-231.
20. Sajatovic M, Gyulai L, Calabrese JR et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry 2005; 13: 305-311.
21. Sajatovic M, Ramsay E, Nanry K, Thompson T. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. Int J Geriatr Psychiatry 2007; 22: 945-950.
22. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders-(SCID) Patient Edition, Version 2.0. New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
24. Williams JB, Kobak KA, Bech P et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol 2008; 23: 120-129.
25. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
26. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
27. Guy W (ed). Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology. Rockville: US Department of Health, Education, and Welfare, 1976.
28. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159-171.
29. Epping-Jordan J, Ustun B. The WHODAS II: Leveling the playing field for all disorders. WHO Bull Ment Health 2000; 6: 5-6.
30. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
31. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334: 1-100.
32. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212: 11-19.
33. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672-676.
34. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
35. Halstead WC. Brain and Intelligence. Chicago: University of Chicago Press, 1947.
36. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsycholgical Test Battery: Therapy and Clinical Interpretation. Tucson: Neuropsychological Press, 1985.
37. Trenerry MR, Crosson B, DeBoe J, Leber WR. The Stroop Neuropsychological Test. Odessa: Psychological Assessment Resources, 1989.
38. Mattis S. Dementia Rating Scale 2 (DRS-2). Lutz: Psychological Assessment Resources, Inc., 2004.
39. Brandt J, Benedict RHB. Hopkins Verbal Learning Test-Revised (HVLT-R). Lutz: Psychological Assessment Resources, Inc., 2001.
40. Miller MD, Paradis CF, Houck PR et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41: 237-248.
41. SAS/STAT Software version 9.2. Cary: SAS Institute, Inc., 2008.
42. Meyers BS, Flint AJ, Rothschild AJ et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs. olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry 2009; 66: 838-847.
43. Marcotte DB. Long-term use of lamotrigine for bipolar disorder in patients over 55years of age. Poster Presentation at the 157th Annual Meeting of the American Psychiatric Association, New York, NY, May 1-6, 2004.
44. Robillard M, Conn DK. Lamotrigine use in geriatric patients with bipolar depression. Can J Psychiatry 2002; 47: 767-770.
45. Rowan AJ, Ramsay RE, Collins JF et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64: 1868-1873.
46. Saetre E, Perucca E, Isojärvi J, Gjerstad L, LAM 40089 Study Group. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007; 48: 1292-1302.
47. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999; 37: 81-87.